|
|
Article: Ampligen trial of CFS patients in Belgium shows significant improvements.
- Article from:
- Business Wire
- Article date:
- October 15, 1996
CopyrightCOPYRIGHT 1996 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
SAN FRANCISCO--(HealthWire)--Oct. 15, 1996--
No evidence of significant toxicities
Results of a Belgium clinical study presented today at the annual scientific meeting of the American Association for Chronic Fatigue Syndrome (AACFS) evidenced that the antiviral and immune modulatory drug Ampligen(R) produced significant physical and cognitive improvements among patients suffering from Chronic Fatigue Syndrome. The study was presented by Kenny De Meirleir, M.D., Ph.D. from the University of Brussels, and by David Strayer, M.D., Professor of Medicine at Allegheny University, PA, and Medical Director for HEMISPHERx.
The ...